Hasan Tahsin Özpolat,Bülent Baran,Filiz Akyüz
Hasan Tahsin Özpolat
Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models [0.03%]
防治酒精使用障碍和酒精相关性肝病的壁垒：实施整合型照护模式的策略
Andrea F DiMartini,Lorenzo Leggio,Ashwani K Singal
Andrea F DiMartini
Despite its increased recognition as a major public health issue, alcohol use disorder is mostly underdiagnosed and undertreated. The undertreatment and underdiagnosis of alcohol use disorder is most concerning in the management of patients...
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives [0.03%]
炎症性肠病生物制剂的治疗药物监测：未满足的需求和未来展望
Konstantinos Papamichael,Waqqas Afif,David Drobne et al.
Konstantinos Papamichael et al.
Therapeutic drug monitoring (TDM) has emerged as a useful tool for optimising the use of biologics, and in particular anti-tumour necrosis factor (anti-TNF) therapy, in inflammatory bowel disease (IBD). However, challenges remain and are hi...
Talha Khan Burki
Talha Khan Burki
Academic diversity programmes for non-US international medical graduates [0.03%]
面向非美国国际医学毕业生的学术多样性项目
Mauricio F Villamar,Ana C Albuja
Mauricio F Villamar
The growth of faecal microbiota transplantation in the UK: time for a registry? [0.03%]
英国粪菌移植的发展：建立注册中心的时机成熟了吗？
David Inglis,Mohammed Nabil Quraishi,Christopher Green et al.
David Inglis et al.
Prevention of bleeding after EMR of colorectal lesions: when and how? [0.03%]
内镜下切除结肠病变后如何预防出血及何时预防？
Sonmoon Mohapatra,Norio Fukami
Sonmoon Mohapatra
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology